New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate ...
Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.
In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...
Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...
The UCLA trial is currently enrolling patients.
University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...
Doctors began testing PSA levels in the 1980s to monitor diagnosed cancers. By the early 1990s, researchers promoted it for ...
PROSTATE cancer has become the most common form of the disease in Britain for the first time. Analysis of NHS figures by ...
The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...
A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...
New Scientist on MSN
Bone cancer therapy unexpectedly makes tumours less painful
A drug that kills cancer cells by puncturing them comes with an additional benefit: tests in mice suggest it reduces the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback